Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "biohackers"


4 mentions found


It hosts testosterone blood-test "T Parties" with tickets costing from $100 to $400. Get the inside scoop on today’s biggest stories in business, from Wall Street to Silicon Valley — delivered daily. He later told Insider in a message on X that his qualifications include "personal experience boosting my T from 790 to 1090 and peer-reviewed research." In May, Tang held a "T Party" in Colombia where he tested 24 men, according to a post on X. Beyond that, Vinjamoori noted that "a single-minded focus on testosterone might not offer the well-rounded approach needed for optimal health and longevity."
Persons: Jeff Tang, Tang, he'd, it's, Anant Vinjamoori, Vinjamoori, he's, Bryan Johnson's Organizations: Service, Party, Athens Research Locations: Athens, Wall, Silicon, San Francisco, Colombia
These drugs tame "zombie cells" which can contribute to age-related diseases. New drugs could clear harmful zombie cells from the body entirely – but research is still ongoing. Metformin is among a class of drugs called "senomorphics," pills that are showing promise taming aging cells known as senescent cells. These are cells in the body that have stopped multiplying, yet don't die—earning them the nickname "zombie cells." For the rest of us, Kirkland says "things like exercise and dieting can reduce senescent cell burden as well."
Sam AltmanOpenAI's Sam Altman reportedly invested $180 million into a longevity startup called Retro Biosciences, according to MIT Technology Review. Lucy Nicholson/ReutersSam Altman is quickly establishing himself as a household name as the CEO of OpenAI, the company behind ChatGPT. Altman seems to be channeling some of his probable largesse into extending the human lifespan. MIT Technology Review reported that Altman invested $180 million into Retro Biosciences, a company with a mission to "add 10 years to healthy human lifespan," according to the company's site. Altman's investment in Retro Biosciences is among the "largest ever by an individual into a startup pursuing human longevity," MTR said.
OpenAI CEO Sam Altman takes the diabetes drug metformin to slow down aging. Metformin is a decades-old drug that is prescribed to millions of people with diabetes, CNBC reported. In addition to the drug, Altman's said his anti-aging regimen includes "trying to eat healthy, exercise, and sleep enough," per the MIT Technology Review. The company uses genetic engineering and plasma replacement to make cells younger, per the MIT Technology Review. Altman secretly poured $180 million dollars into Retro Bioscience's death-delaying treatment, the MIT Technology Review reported.
Total: 4